Orasis Pharmaceuticals developed Qlosi, a corrective eye drop for the treatment of presbyopia in adults. Orasis is led by a collaborative team of industry executives and eye care professionals with a broad range of experiences in research, development, and commercialization of pharmaceutical drugs, as well as finance and business development. Orasis is funded by a diverse group of sophisticated and experienced life science and healthcare investors.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/08/24 | $78,000,000 | Series D |
Arboretum Ventures Bluestem Capital Catalio Capital Management Freepoint Capital Group Johnson & Johnson Innovation Maverick Ventures SBI JI Innovation Fund Sequoia Capital Visionary Ventures Fund | undisclosed |
